Edy Meiyanto Selected Research

Proteins (Proteins, Gene)

12/2022	Piperine Increases Pentagamavunon-1 Anti-cancer Activity on 4T1 Breast Cancer Through Mitotic Catastrophe Mechanism and Senescence with Sharing Targeting on Mitotic Regulatory Proteins.
2/2022	The Cytotoxic and Anti-Migratory Properties of Caesalpinia sappan and Ficus septica, in Combination with Doxorubicin on 4T1 TNBC Cells with Nephroprotective Potential.
9/2021	The Growth Suppression Activity of Diosmin and PGV-1 Co-Treatment on 4T1 Breast Cancer Targets Mitotic Regulatory Proteins.
1/2021	The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edy Meiyanto Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2012
22	Neoplasms (Cancer) 01/2024 - 01/2012
8	Triple Negative Breast Neoplasms 01/2023 - 01/2021
4	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2016
3	Colonic Neoplasms (Colon Cancer) 10/2023 - 09/2017
3	Leukemia 07/2023 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 07/2023
2	Carcinogenesis 01/2021 - 11/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2019
1	Adenocarcinoma 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Osteoporosis 01/2012

Drug/Important Bio-Agent (IBA)

15	CurcuminIBA 01/2024 - 01/2014
12	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2023 - 01/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2021
3	HesperidinIBA 03/2023 - 01/2012
3	EnzymesIBA 11/2019 - 01/2018
2	FlavonoidsIBA 03/2023 - 01/2012
2	BoronIBA 01/2022 - 08/2019
2	Antineoplastic Agents (Antineoplastics)IBA 06/2021 - 01/2021
2	Ethanol (Ethyl Alcohol)IBA 02/2021 - 04/2019
2	AntioxidantsIBA 01/2021 - 11/2019
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2012
1	Monoclonal AntibodiesIBA 12/2023
1	Dimenhydrinate (DMH)FDA LinkGeneric 10/2023
1	GlycosidesIBA 03/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	CXC ChemokinesIBA 01/2023
1	mangostinIBA 01/2023
1	piperineIBA 12/2022
1	caryophylleneIBA 01/2022
1	CB2 Cannabinoid ReceptorIBA 01/2022
1	CannabinoidsIBA 01/2022
1	Diosmin (Daflon)IBA 09/2021
1	Cell Cycle ProteinsIBA 09/2021
1	human ERBB2 proteinIBA 06/2021
1	Trastuzumab (Herceptin)FDA Link 02/2021
1	GelatinIBA 01/2021
1	methylamphotericin B (AME)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 10/2020
1	allylthioureaIBA 10/2020
1	hesperetinIBA 05/2020
1	Cysteine (L-Cysteine)FDA Link 11/2019
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2018
1	Alcohol OxidoreductasesIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	brazilinIBA 09/2017
1	brazileinIBA 09/2017
1	PotassiumIBA 01/2016
1	SaltsIBA 01/2016
1	pentagamavunon-0IBA 01/2016
1	n-hexaneIBA 04/2013
1	ethyl acetateIBA 10/2012
1	Tamoxifen FDA LinkGeneric 01/2012
1	HexanesIBA 01/2012
1	tangeretinIBA 01/2012
1	LipidsIBA 01/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2024 - 10/2012
6	Therapeutics 12/2023 - 01/2012
3	Chemoprevention 10/2023 - 06/2021
2	Boron Neutron Capture Therapy 01/2022 - 12/2019
1	Oral Administration 10/2019